The letter, which was signed by Dr. Homayoon Khanlou, Chief of Medication/US and Michael Weinstein, AHF President, mentioned: This letter can be to inform you that effective instantly, Merck product sales representatives are no more granted usage of these [AHF Health care] centers. As AHF offers repeatedly pointed out to Merck regarding this matter, there is no justification for Isentress to be priced as a salvage medication given that the FDA has authorized it for first-line make use of, vastly increasing its market. It is 100 percent pure greed. Related StoriesRE.Function showcases future technology and innovations in deep learning softwareApplying a high restaurant model to healthcare communications: an interview with Brandi Robinson, SanofiSurgical startup seeks funding to build virtual actuality schooling libraryYour refusal to lessen the unwarranted price charged for Isentress is causing great injury to State AIDS Drug Assistance Programs , and to people who have HIV/AIDS who rely on them.Health officials state at this stage it is too early to determine if the brand new epidemic outbreak is in fact a haemorrhagic fever.
ASE releases set of recommendations for quality echocardiography laboratory operations The American Society of Echocardiography released a set of recommendations and measurable standards for quality in the echocardiography laboratory today. The recommendations for quality echocardiography laboratory functions will be released in the January problem of the Journal of the American Society of Echocardiography . The objective of the survey is to supply a framework for echocardiographic quality evaluation and improvement, and to offer standards that are realistic goals for each practitioner, stated Michael H. Picard, MD, FASE, the lead author of the record, a former president of the ASE and the Director of Echocardiography at the Massachusetts General Hospital.